Predictors of immunotherapeutic benefits in patients with advanced melanoma and other malignancies treated with immune checkpoint inhibitors utilizing ORIEN "real-world" data

被引：0
|
作者：
Tarhini, Ahmad A.
Tan, Aik Choon
Xie, Mengyu
El Naqa, Issam
Saghand, Payman Ghasemi
Dai, Donghai
Chen, James Lin
Ratan, Aakrosh
McCarter, Martin
Carpten, John D.
Colman, Howard
Ikeguchi, Alexandra
Tripathi, Abhishek
Puzanov, Igor
Arnold, Susanne M.
Churchman, Michelle L.
Hwu, Patrick
Conejo-Garcia, Jose
Dalton, William S.
Weiner, George J.
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, l, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA USA
[4] Ohio State Univ, Columbus, OH USA
[5] Univ Virginia, Charlottesville, VA USA
[6] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA
[7] Univ Southern Calif, Los Angeles, CA USA
[8] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[9] Univ Oklahoma, Oklahoma City, OK USA
[10] Univ Oklahoma, Stephenson Canc Ctr, Hlth Sci Ctr, Oklahoma City, OK USA
[11] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[12] Univ Kentucky, Lexington, KY USA
[13] M2Gen, Tampa, FL USA
[14] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2618
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Retreatment with immune checkpoint inhibitors (ICIs) for patients with advanced gastric cancer: A retrospective, real-world study.
    Jia, Yong-Xu
    Liu, Yihan
    Han, Hui-Qiong
    Gao, Ya-Ping
    Qin, Yanru
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 343 - 343
  • [42] Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer
    Zhang, Shijia
    Pease, Daniel F.
    Kulkarni, Amit A.
    Kumar, Manoj
    Shanley, Ryan M.
    Xu, Beibei
    Joshi, Shilvi P.
    Patel, Manish R.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [43] Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Kim, Jwa Hoon
    Ahn, Bokyung
    Hong, Seung-Mo
    Jung, Hwoon-Yong
    Kim, Do Hoon
    Choi, Kee Don
    Ahn, Ji Yong
    Lee, Jeong Hoon
    Na, Hee Kyoung
    Kim, Jong Hoon
    Kim, Yong-Hee
    Kim, Hyeong Ryul
    Lee, Hyun Joo
    Kim, Sung-Bae
    Park, Sook Ryun
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 505 - 516
  • [44] A deep learning approach utilizing clinical and molecular data for identifying prognostic biomarkers in patients treated with immune checkpoint inhibitors: An ORIEN pan-cancer study
    Saghand, Payman Ghasemi
    El Naqa, Issam
    Tan, Aik Choon
    Xie, Mengyu
    Dai, Donghai
    Chen, James Lin
    Ratan, Aakrosh
    McCarter, Martin
    Carpten, John D.
    Shah, Harsh
    Ikeguchi, Alexandra
    Tripathi, Abhishek
    Puzanov, Igor
    Arnold, Susanne M.
    Churchman, Michelle L.
    Hwu, Patrick
    Conejo-Garcia, Jose
    Dalton, William S.
    Weiner, George J.
    Tarhini, Ahmad A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
    Hanna, Glenn J.
    Ruiz, Emily S.
    LeBoeuf, Nicole R.
    Thakuria, Manisha
    Schmults, Chrysalyne D.
    Decaprio, James A.
    Silk, Ann W.
    BRITISH JOURNAL OF CANCER, 2020, 123 (10) : 1535 - 1542
  • [46] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
    Lippenszky, Levente
    Mittendorf, Kathleen F.
    Kiss, Zoltan
    LeNoue-Newton, Michele L.
    Napan-Molina, Pablo
    Rahman, Protiva
    Ye, Cheng
    Laczi, Balazs
    Csernai, Eszter
    Jain, Neha M.
    Holt, Marilyn E.
    Maxwell, Christina N.
    Ball, Madeleine
    Ma, Yufang
    Mitchell, Margaret B.
    Johnson, Douglas B.
    Smith, David S.
    Park, Ben H.
    Micheel, Christine M.
    Fabbri, Daniel
    Wolber, Jan
    Osterman, Travis J.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [47] Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data
    Kanayama, Masatoshi
    Manabe, Takehiko
    Yoshimatsu, Katsuma
    Oyama, Rintaro
    Matsumiya, Hiroki
    Mori, Masataka
    Takenaka, Masaru
    Kuroda, Koji
    Tanaka, Fumihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, : 705 - 717
  • [48] Prediction of Effectiveness and Toxicities of Immune Checkpoint Inhibitors Using Real-World Patient Data
    Lippenszky, Levente
    Mittendorf, Kathleen F.
    Kiss, Zoltan
    LeNoue-Newton, Michele L.
    Napan-Molina, Pablo
    Rahman, Protiva
    Ye, Cheng
    Laczi, Balazs
    Csernai, Eszter
    Jain, Neha M.
    Holt, Marilyn E.
    Maxwell, Christina N.
    Ball, Madeleine
    Ma, Yufang
    Mitchell, Margaret B.
    Johnson, Douglas B.
    Smith, David S.
    Park, Ben H.
    Micheel, Christine M.
    Fabbri, Daniel
    Wolber, Jan
    Osterman, Travis J.
    JCO CLINICAL CANCER INFORMATICS, 2024, 8
  • [49] CARDIOVASCULAR OUTCOMES MEASURED BY ADJUDICATION VERSUS BILLING CODES IN REAL-WORLD PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS
    Kondapalli, Lavanya
    Thurston, Jessica
    Hsia, Judith
    Miller, Ronni
    Dale, Rita
    Bonaca, Marc
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3321 - 3321
  • [50] Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma
    Luke S. McLean
    Annette M. Lim
    Mathias Bressel
    Alesha A. Thai
    Danny Rischin
    Drugs & Aging, 2024, 41 : 271 - 281
12345